Partial depletion of striatal dopamine enhances penetrance of cognitive deficits in a transgenic mouse model of Alzheimer's disease

Cerebral Cortical Aβ42and PHF-τ in 325 Consecutive Brain Autopsies Stratified by Diagnosis, Location, andAPOE

(2015) Nadia Postupna et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Familial Coaggregation of Alzheimer's Disease and Parkinson's Disease: Systematic Review and Meta-Analysis

(2014) Adina L. Feldman et al.   NEUROEPIDEMIOLOGY

CSF A 42 predicts early-onset dementia in Parkinson disease

(2014) G. Alves et al.   NEUROLOGY

Recommendations of the Alzheimer's Disease-Related Dementias Conference

(2014) T. J. Montine et al.   NEUROLOGY

APOE3, but Not APOE4, Bone Marrow Transplantation Mitigates Behavioral and Pathological Changes in a Mouse Model of Alzheimer Disease

(2013) Yue Yang et al.   AMERICAN JOURNAL OF PATHOLOGY

Distinct α-Synuclein Strains Differentially Promote Tau Inclusions in Neurons

(2013) Jing L. Guo et al.   CELL

Evidence for modest familial co-aggregation between dementia and parkinsonism

(2013) Adina L. Feldman et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Ablation of the microglial protein DOCK2 reduces amyloid burden in a mouse model of Alzheimer's disease

(2013) Patrick J. Cimino et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease

(2012) Bradley T. Hyman et al.   Alzheimers & Dementia

Neuropathologic substrates of Parkinson disease dementia

(2012) David J. Irwin et al.   ANNALS OF NEUROLOGY

Antagonism of Neuronal Prostaglandin E2 Receptor Subtype 1 Mitigates Amyloid β Neurotoxicity In Vitro

(2012) Xianwu Li et al.   Journal of Neuroimmune Pharmacology

National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach

(2011) Thomas J. Montine et al.   ACTA NEUROPATHOLOGICA

Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Reisa A. Sperling et al.   Alzheimers & Dementia

Stress, exercise, and Alzheimer’s disease: A neurovascular pathway

(2011) Daniel A. Nation et al.   MEDICAL HYPOTHESES

Contributions of Striatal Dopamine Signaling to the Modulation of Cognitive Flexibility

(2010) Martin Darvas et al.   BIOLOGICAL PSYCHIATRY

The Epidemiology of Dementia Associated with Parkinson's Disease

(2010) Dag Aarsland et al.   BRAIN PATHOLOGY

Activation of D1/D5 Dopamine Receptors Protects Neurons from Synapse Dysfunction Induced by Amyloid-β Oligomers

(2010) Sofia Jürgensen et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

CSF amyloid-  and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study

(2010) G. Alves et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Synergistic Interactions between A , Tau, and  -Synuclein: Acceleration of Neuropathology and Cognitive Decline

(2010) L. K. Clinton et al.   JOURNAL OF NEUROSCIENCE

CSF Aβ42and tau in Parkinson's disease with cognitive impairment

(2010) Thomas J. Montine et al.   MOVEMENT DISORDERS

CSF amyloid   1-42 predicts cognitive decline in Parkinson disease

(2010) A. Siderowf et al.   NEUROLOGY

Quantitation and Mapping of Cerebral Detergent-Insoluble Proteins in the Elderly

(2008) Randall L. Woltjer et al.   BRAIN PATHOLOGY

Imaging amyloid deposition in Lewy body diseases

(2008) S. N. Gomperts et al.   NEUROLOGY